Technical Analysis for AVRO - AVROBIO, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.20 | -3.23% | -0.04 |
AVRO closed down 3.23 percent on Friday, April 19, 2024, on 19 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Lower Bollinger Band Walk | Weakness | -3.23% | |
Inside Day | Range Contraction | -3.23% | |
Gapped Up | Strength | -3.23% | |
Lower Bollinger Band Touch | Weakness | -3.23% |
Alert | Time |
---|---|
Down 3% | about 9 hours ago |
Possible NR7 | about 10 hours ago |
Fell Below Lower Bollinger Band | about 11 hours ago |
Fell Below Previous Day's Low | about 11 hours ago |
Down 2 % | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Virotherapy Gene Therapy Medical Genetics Genetic Engineering Gene Delivery
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Virotherapy Gene Therapy Medical Genetics Genetic Engineering Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.7 |
52 Week Low | 0.57 |
Average Volume | 210,328 |
200-Day Moving Average | 1.40 |
50-Day Moving Average | 1.28 |
20-Day Moving Average | 1.26 |
10-Day Moving Average | 1.25 |
Average True Range | 0.05 |
RSI (14) | 36.71 |
ADX | 40.48 |
+DI | 8.09 |
-DI | 23.78 |
Chandelier Exit (Long, 3 ATRs) | 1.16 |
Chandelier Exit (Short, 3 ATRs) | 1.30 |
Upper Bollinger Bands | 1.31 |
Lower Bollinger Band | 1.21 |
Percent B (%b) | -0.1 |
BandWidth | 8.16 |
MACD Line | -0.02 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0052 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.25 | ||||
Resistance 3 (R3) | 1.26 | 1.24 | 1.24 | ||
Resistance 2 (R2) | 1.24 | 1.23 | 1.24 | 1.24 | |
Resistance 1 (R1) | 1.22 | 1.22 | 1.22 | 1.22 | 1.24 |
Pivot Point | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 |
Support 1 (S1) | 1.19 | 1.19 | 1.18 | 1.18 | 1.16 |
Support 2 (S2) | 1.17 | 1.19 | 1.17 | 1.16 | |
Support 3 (S3) | 1.15 | 1.17 | 1.16 | ||
Support 4 (S4) | 1.15 |